Abstract
We sought to evaluate reports that rosuvastatin 10 mg is a more efficacious treatment of hyperlipidaemia than is simvastatin 40 mg, hoping to assess this issue in the previously unstudied context of acute myocardial infarction.
Original language | English |
---|---|
Pages (from-to) | 712-21 |
Number of pages | 10 |
Journal | European Journal of Cardiovascular Prevention and Rehabilitation |
Volume | 16 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec 2009 |
Keywords
- Aged
- Biological Markers
- Cholesterol
- Cholesterol, LDL
- Female
- Fluorobenzenes
- Great Britain
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hyperlipidemias
- Male
- Middle Aged
- Myocardial Infarction
- Odds Ratio
- Practice Guidelines as Topic
- Prospective Studies
- Pyrimidines
- Recurrence
- Secondary Prevention
- Simvastatin
- Sulfonamides
- Time Factors
- Treatment Outcome